Clinical trial
A Study of Solifenacin Succinate Compared to Tolterodine in Patients With…
NCT00189800 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00189800 |
|---|---|
| Title | A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Collaborators | Astellas Pharma Korea, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Overactive Bladder |
| Intervention type | Drug |
| Interventions | Solifenacin succinate |
| First posted | Sep 19, 2005 |
| Last update posted | Nov 17, 2011 |
| Countries | South Korea |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: